{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/15/3311797/0/en/ENDO-2026-Oral-Presentation-Highlights-Comparative-Clinical-Data-for-Entera-s-Breakthrough-Single-Tablet-EB613-First-in-Class-Oral-PTH-1-34-Anabolic-for-Osteoporosis.html", "message": "News view counter 798947 successfully enlarged"}